Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
CYBER ENVIRO-TECH CREATES INTERNATIONAL PRESENCE IN TURKEY
09:43am, Thursday, 27'th Feb 2025
SCOTTSDALE, Ariz. , Feb. 27, 2025 /PRNewswire/ -- Cyber Enviro-Tech Inc. (CETI) (OTCQB: CETI) is pleased to announce the formation of a Turkish subsidiary, Cyber International Ltd (C-INT), with an of
Bio-Techne: Attractive Markets And A Good Moat, But Valuation Is Seldom A Bargain
09:00am, Thursday, 27'th Feb 2025
Bio-Techne's shares have been pressured lately on concerns about the academic research market and biopharma R&D restructuring, but core business trends look largely intact. Fiscal Q2 showed revenue gr
Bio-Techne to Present at Investor Conferences
07:00am, Thursday, 27'th Feb 2025
MINNEAPOLIS , Feb. 27, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: TD Cowen 45th Annual Health Care Conferenc
CMB.TECH announces Q4 2024 results
01:05am, Thursday, 27'th Feb 2025
CMB.TECH ANNOUNCES Q4 2024 RESULTS STRONG RESULTS DESPITE SLOW MARKETS ANTWERP, Belgium, 27 February 2025 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT & Euronext: CMBT
EXEL or TECH: Which Is the Better Value Stock Right Now?
12:45pm, Monday, 24'th Feb 2025
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Exelixis (EXEL) and Techne (TECH). But which of these two stocks is more attractive to value investo
Bio-Techne Stock Set to Benefit From Expansion of RNAscope Menu
08:36am, Monday, 24'th Feb 2025
TECH unveils the RNAscope Probes menu for human and mouse transcriptome to advance spatial biology.
YSX TECH. CO. LTD Announces Unaudited Financial Results for the Six Months Ended September 30, 2024
08:30am, Monday, 24'th Feb 2025
GUANGZHOU, China, Feb. 24, 2025 (GLOBE NEWSWIRE) -- YSX TECH. CO., LTD (the “Company” or “YSXT”), a Cayman Islands exempted company that, through its variable interest entities in China, provi
Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
07:00am, Thursday, 20'th Feb 2025
MINNEAPOLIS , Feb. 20, 2025 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope™
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
07:00am, Tuesday, 18'th Feb 2025
MINNEAPOLIS , Feb. 18, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools, is pleased to announce the official release of GMP Tra
CMB.TECH announces Q4 2024 results on 27/02/2025
02:21am, Thursday, 13'th Feb 2025
Antwerp, Feb. 13, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMBT”, “CMB.TECH” or “the Company”) will release its fourth quarter 2024 earnings prior to market ope
EXEL or TECH: Which Is the Better Value Stock Right Now?
12:40pm, Thursday, 06'th Feb 2025
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Exelixis (EXEL) and Techne (TECH). But which of these two stocks is more attractive to v
Bio-Techne Tops Q2 Earnings & Revenue Estimates, Stock Up in Premarket
03:01pm, Wednesday, 05'th Feb 2025
TECH registers continued growth momentum across its Diagnostics & Spatial Biology segment.
Bio-Techne Corporation (TECH) Q2 2025 Earnings Call Transcript
02:24pm, Wednesday, 05'th Feb 2025
Bio-Techne Corporation (NASDAQ:TECH ) Q2 2025 Earnings Conference Call February 5, 2025 9:00 AM ET Company Participants David Clair - Vice President-Investor Relations Kim Kelderman - President and Ch
Techne (TECH) Tops Q2 Earnings and Revenue Estimates
08:45am, Wednesday, 05'th Feb 2025
Techne (TECH) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.40 per share a year ago.
Bio-Techne Declares Dividend
06:30am, Wednesday, 05'th Feb 2025
MINNEAPOLIS , Feb. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended Decembe
